Gupta Vinod Kumar
Dubai Police Medical Services, P.O. Box 12005, Dubai, United Arab Emirates.
Med Hypotheses. 2006;66(3):454-60. doi: 10.1016/j.mehy.2005.11.010. Epub 2005 Dec 13.
Brain neuronal dysfunction has been implicated in pathogenesis of migraine but direct evidence is lacking. Scintillating scotoma of migraine is generally believed to originate at the visual cortex. While cortical spreading depression is a relatively late physiological alteration in migraine, its protective role in neuronal ischaemia is increasingly being recognized. Atenolol, nadolol, or verapamil prevent migraine but do not readily cross the blood-brain barrier or critically influence any brain or peripheral neuronal function. Typical migraine headache, aura, or scintillating scotoma has not been reported following enucleation or evisceration of the eye. In humans, pain and temperature fibres from only the ophthalmic division of the trigeminal nerve reach the upper cervical spinal segments. Pain in migraine attacks including occipital and nuchal discomfort reflects selective involvement of the ophthalmic nerve. Photophobia is largely a retinal reflex involving the ophthalmic division of the trigeminal nerve. Key clinical features of the migrainous scintillating scotoma are consistent with retinal origin. Spreading depression in the retina is well-established. A subtle regional ocular sympathetic deficit prevails in migraine patients and possibly impairs regulation of intraocular choroidal blood volume and intraocular pressure. Several first-line migraine prophylactic agents lower the intraocular pressure. The neuro-ophthalmological basis for a monocular origin of migrainous scintillating scotomata due to mechanical deformation of the posterior segment of the corneo-scleral envelope consequent to choroidal venous congestion and rise in intraocular pressure is presented. Study of distribution and displaceability of the migrainous scintillating scotoma can settle its site of origin. Headache of migraine possibly arises from a similar mechanical deformation of the anterior eye segment followed by antidromic discharge in the trigeminovascular system. Lateralizing negative deficits such as homonymous hemianopia probably reflect vasospastic complications of migraine. A rational explanation for the most characteristic clinical features of migraine and a new template to elucidate the pharmacological basis of anti-migraine drugs is offered.
脑神经元功能障碍被认为与偏头痛的发病机制有关,但缺乏直接证据。偏头痛的闪烁暗点通常被认为起源于视觉皮层。虽然皮层扩散性抑制是偏头痛中相对较晚出现的生理改变,但其在神经元缺血中的保护作用正日益受到认可。阿替洛尔、纳多洛尔或维拉帕米可预防偏头痛,但不易穿过血脑屏障,也不会对任何脑或外周神经元功能产生关键影响。眼球摘除或眼内容剜出术后未报告出现典型偏头痛性头痛、先兆或闪烁暗点。在人类中,仅三叉神经眼支的痛觉和温度觉纤维到达上颈段脊髓节段。偏头痛发作时的疼痛,包括枕部和颈部不适,反映了眼神经的选择性受累。畏光主要是一种涉及三叉神经眼支的视网膜反射。偏头痛性闪烁暗点的关键临床特征与视网膜起源一致。视网膜中的扩散性抑制已得到充分证实。偏头痛患者普遍存在轻微的局部眼交感神经功能缺陷,可能会损害眼脉络膜血容量和眼压的调节。几种一线偏头痛预防性药物可降低眼压。本文提出了偏头痛性闪烁暗点单眼起源的神经眼科基础,即由于脉络膜静脉充血和眼压升高导致角膜巩膜包膜后段机械变形。对偏头痛性闪烁暗点的分布和可移位性的研究可以确定其起源部位。偏头痛性头痛可能源于眼前段类似的机械变形,随后三叉神经血管系统发生逆向放电。诸如同向性偏盲等偏侧性负性缺陷可能反映了偏头痛的血管痉挛并发症。本文为偏头痛最具特征性的临床特征提供了合理的解释,并为阐明抗偏头痛药物的药理基础提供了一个新的模板。